RTX vs VTGN · P/E 36, rev $88.60B vs rev $176.0K
RTX Corporation (RTX) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
Latest reported RTX revenue for 2025-12-31 was $88.60B. Net income was $6.73B. Revenue was up 9.7% from 2024-12-31 to 2025-12-31. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
RTX currently screens at market cap $259.34B and trailing P/E 36.2. VTGN currently screens at market cap $28.1M.
Not investment advice. Open the RTX and VTGN stock pages for the full models.
Not investment advice.